UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Regulatory T cells in psoriatic arthritis: an IL-17A-producing, Foxp3intCD161 + RORγt + ICOS + phenotype, that associates with the presence of ADAMTSL5 autoantibodies

Scientific reports, 2022-11, Vol.12 (1), p.20675-20675, Article 20675

2022

Volltextzugriff (PDF)

Author Correction: Regulatory T cells in psoriatic arthritis: an IL-17A-producing, Foxp3intCD161 + RORγt + ICOS + phenotype, that associates with the presence of ADAMTSL5 autoantibodies

Scientific reports, 2023-01, Vol.13 (1), p.1348-1348, Article 1348

2023

Volltextzugriff (PDF)

Suppression of IL‐12/IL‐23 p40 subunit in the skin and blood of psoriasis patients by Tofacitinib is dependent on active interferon‐γ signaling in dendritic cells: Implications for the treatment of psoriasis and interferon‐driven diseases

Experimental dermatology, 2022-06, Vol.31 (6), p.962-969

2022

Volltextzugriff (PDF)

Review: Innate Lymphoid Cells: Sparking Inflammatory Rheumatic Disease?

Arthritis & rheumatology (Hoboken, N.J.), 2017-05, Vol.69 (5), p.885-897

2017

Volltextzugriff (PDF)

Perception of self: distinguishing autoimmunity from autoinflammation

Nature reviews. Rheumatology, 2015-08, Vol.11 (8), p.483-492

2015

Volltextzugriff (PDF)

Impaired proteolysis by SPPL2a causes CD74 fragment accumulation that can be recognized by anti‐CD74 autoantibodies in human ankylosing spondylitis

European journal of immunology, 2020-08, Vol.50 (8), p.1209-1219

2020

Volltextzugriff (PDF)

TOFA-PREDICT study protocol: a stratification trial to determine key immunological factors predicting tofacitinib efficacy and drug-free remission in psoriatic arthritis (PsA)

BMJ open, 2022-10, Vol.12 (10), p.e064338

2022

Volltextzugriff (PDF)

Activation-induced colocalisation of SCAMP5 with IFNα in human plasmacytoid dendritic cells

Lupus science & medicine, 2022-03, Vol.9 (1), p.e000680

2022

Volltextzugriff (PDF)

Longitudinal Follow-Up Using the Heel Enthesitis Magnetic Resonance Imaging Scoring System (HEMRIS) Shows Minimal Changes in Heel Enthesitis Assessed in Spondyloarthritis and Psoriasis Patients

Journal of personalized medicine, 2022-10, Vol.12 (11), p.1765

2022

Volltextzugriff (PDF)

Comparison of the Heel Enthesitis MRI Scoring System (HEMRIS) with clinical enthesitis and local metabolic activity on PET-CT

Rheumatic & musculoskeletal diseases open, 2020-11, Vol.6 (3), p.e001424

2020

Volltextzugriff (PDF)

ZFP36 Family Members Regulate the Proinflammatory Features of Psoriatic Dermal Fibroblasts

Journal of investigative dermatology, 2022-02, Vol.142 (2), p.402-413

2022

Volltextzugriff (PDF)

A precision medicine trial in psoriatic arthritis-first jump in the deep end

Rheumatology (Oxford, England), 2019-02, Vol.58 (2), p.189-190

Leijten, Emmerik F A

2019

Volltextzugriff (PDF)

MYOSITIS, 1st edition, edited by H. Chinoy and R.G. Cooper

Rheumatology (Oxford, England), 2019-01, Vol.58 (1), p.e1-e1

Leijten, Emmerik F A

2019

Volltextzugriff (PDF)

Brief Report: Enrichment of Activated Group 3 Innate Lymphoid Cells in Psoriatic Arthritis Synovial Fluid

Arthritis & rheumatology (Hoboken, N.J.), 2015-10, Vol.67 (10), p.2673-2678

2015

Volltextzugriff (PDF)

First-line csDMARD monotherapy drug retention in psoriatic arthritis: methotrexate outperforms sulfasalazine

Rheumatology (Oxford, England), 2021-02, Vol.60 (2), p.780-784

2021

Volltextzugriff (PDF)

Increased expression of Fas on group 2 and 3 innate lymphoid cells is associated with an interferon signature in systemic lupus erythematosus and Sjögren’s syndrome

Rheumatology (Oxford, England), 2019-10, Vol.58 (10), p.1740-1745

2019

Volltextzugriff (PDF)

Do Patients with Psoriatic Arthritis Have More Severe Skin Disease than Patients with Psoriasis Only? A Systematic Review and Meta-Analysis

Dermatology (Basel), 2022-11, Vol.238 (6), p.1108-1119

2022

Volltextzugriff (PDF)

CXCL4 is a novel inducer of human Th17 cells and correlates with IL‐17 and IL‐22 in psoriatic arthritis

European journal of immunology, 2018-03, Vol.48 (3), p.522-531

2018

Volltextzugriff (PDF)

A pan‐inflammatory microRNA‐cluster is associated with orbital non‐Hodgkin lymphoma and idiopathic orbital inflammation

European journal of immunology, 2020-01, Vol.50 (1), p.86-96

2020

Volltextzugriff (PDF)

DNAM1 and TIGIT balance the T cell response, with low T cell TIGIT expression corresponding to inflammation in psoriatic disease

Immunotherapy advances, 2021-01, Vol.1 (1), p.ltaa004-ltaa004

2021

Volltextzugriff (PDF)

Author Correction: Regulatory T cells in psoriatic arthritis: an IL-17A-producing, Foxp3 int CD161 + RORγt + ICOS + phenotype, that associates with the presence of ADAMTSL5 autoantibodies

Scientific reports, 2023-01, Vol.13 (1), p.1348

2023

Volltextzugriff (PDF)

Regulatory T cells in psoriatic arthritis: an IL-17A-producing, Foxp3 int CD161 + RORγt + ICOS + phenotype, that associates with the presence of ADAMTSL5 autoantibodies

Scientific reports, 2022-11, Vol.12 (1), p.20675

2022

Volltextzugriff (PDF)

Tissue‐Resident Memory CD8+ T Cells From Skin Differentiate Psoriatic Arthritis From Psoriasis

Arthritis & rheumatology (Hoboken, N.J.), 2021-07, Vol.73 (7), p.1220-1232

2021

Volltextzugriff (PDF)

Limits of traditional evidence-based medicine methodologies exemplified by the novel era in psoriatic arthritis drug development

Expert review of clinical immunology, 2019-05, Vol.15 (5), p.441-444

2019

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Regulatory T cells in psoriatic arthritis: an IL-17A-producing, Foxp3intCD161 + RORγt + ICOS + phenotype, that associates with the presence of ADAMTSL5 autoantibodies

Author Correction: Regulatory T cells in psoriatic arthritis: an IL-17A-producing, Foxp3intCD161 + RORγt + ICOS + phenotype, that associates with the presence of ADAMTSL5 autoantibodies

Suppression of IL‐12/IL‐23 p40 subunit in the skin and blood of psoriasis patients by Tofacitinib is dependent on active interferon‐γ signaling in dendritic cells: Implications for the treatment of psoriasis and interferon‐driven diseases

Review: Innate Lymphoid Cells: Sparking Inflammatory Rheumatic Disease?

Perception of self: distinguishing autoimmunity from autoinflammation

Impaired proteolysis by SPPL2a causes CD74 fragment accumulation that can be recognized by anti‐CD74 autoantibodies in human ankylosing spondylitis

TOFA-PREDICT study protocol: a stratification trial to determine key immunological factors predicting tofacitinib efficacy and drug-free remission in psoriatic arthritis (PsA)

Activation-induced colocalisation of SCAMP5 with IFNα in human plasmacytoid dendritic cells

Longitudinal Follow-Up Using the Heel Enthesitis Magnetic Resonance Imaging Scoring System (HEMRIS) Shows Minimal Changes in Heel Enthesitis Assessed in Spondyloarthritis and Psoriasis Patients

Comparison of the Heel Enthesitis MRI Scoring System (HEMRIS) with clinical enthesitis and local metabolic activity on PET-CT

ZFP36 Family Members Regulate the Proinflammatory Features of Psoriatic Dermal Fibroblasts

A precision medicine trial in psoriatic arthritis-first jump in the deep end

MYOSITIS, 1st edition, edited by H. Chinoy and R.G. Cooper

Brief Report: Enrichment of Activated Group 3 Innate Lymphoid Cells in Psoriatic Arthritis Synovial Fluid

First-line csDMARD monotherapy drug retention in psoriatic arthritis: methotrexate outperforms sulfasalazine

Increased expression of Fas on group 2 and 3 innate lymphoid cells is associated with an interferon signature in systemic lupus erythematosus and Sjögren’s syndrome

Do Patients with Psoriatic Arthritis Have More Severe Skin Disease than Patients with Psoriasis Only? A Systematic Review and Meta-Analysis

CXCL4 is a novel inducer of human Th17 cells and correlates with IL‐17 and IL‐22 in psoriatic arthritis

A pan‐inflammatory microRNA‐cluster is associated with orbital non‐Hodgkin lymphoma and idiopathic orbital inflammation

DNAM1 and TIGIT balance the T cell response, with low T cell TIGIT expression corresponding to inflammation in psoriatic disease

Author Correction: Regulatory T cells in psoriatic arthritis: an IL-17A-producing, Foxp3 int CD161 + RORγt + ICOS + phenotype, that associates with the presence of ADAMTSL5 autoantibodies

Regulatory T cells in psoriatic arthritis: an IL-17A-producing, Foxp3 int CD161 + RORγt + ICOS + phenotype, that associates with the presence of ADAMTSL5 autoantibodies

Tissue‐Resident Memory CD8+ T Cells From Skin Differentiate Psoriatic Arthritis From Psoriasis

Limits of traditional evidence-based medicine methodologies exemplified by the novel era in psoriatic arthritis drug development

Suchergebnisse filtern